Futura Medical - Notice of Interim Results | 18-Aug-2023 | 07:00 | RNS |
MED3000 Commercialisation Approval in Saudi Arabia | 09-Aug-2023 | 07:00 | RNS |
Futura Medical - Total Voting Rights | 31-Jul-2023 | 07:00 | RNS |
Board Change | 18-Jul-2023 | 11:04 | RNS |
Futura/Haleon Enter US Commercialisation Agreement | 17-Jul-2023 | 07:00 | RNS |
Futura Medical - Total Voting Rights | 30-Jun-2023 | 07:00 | RNS |
Futura Medical Annual General Meeting Results | 22-Jun-2023 | 15:19 | RNS |
Futura Medical AGM Statement | 22-Jun-2023 | 07:00 | RNS |
Correction - TR-1: Notification of major holdings | 19-Jun-2023 | 10:25 | RNS |
TR-1: Notification of major holdings | 16-Jun-2023 | 16:05 | RNS |
Exercise of Warrants | 12-Jun-2023 | 08:23 | RNS |
MED3000 Granted US FDA Approval for OTC Sale | 12-Jun-2023 | 07:00 | RNS |
Futura Medical Announces Investor Seminar | 08-Jun-2023 | 07:00 | RNS |
Block Listing Six Monthly Return | 31-May-2023 | 07:00 | RNS |
Notice of AGM and availability of Annual Report | 26-May-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 35.65p |
Change Today | 0.15p |
% Change | 0.42 % |
52 Week High | 65.00 |
52 Week Low | 25.50 |
Volume | 425,659 |
Shares Issued | 301.45m |
Market Cap | £107.47m |
RiskGrade | 479 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
16:15 | 31,942 @ 35.49p |
16:15 | 171 @ 35.40p |
16:15 | 875 @ 35.40p |
16:15 | 5,896 @ 35.40p |
15:52 | 10,000 @ 35.52p |
CEO | James Henry Barder |
Finance Director | Angela Hildreth |
You are here: research